Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Brochure More information from http://www.researchandmarkets.com/reports/2860693/ Schizophrenia Therapeutics: A Market Briefing Description: Schizophrenia is a life long affliction. There is no permanent cure for this illness. However, numerous drugs have made the effective management of the disease a reality. This briefing examines both corrent and emerging therapeutic approaches for the management of schizophrenia. It provides an analysis of the current and future markets for these agents, including forecasts to 2009 segmented by geographic region and by type of drug and likely market scenarios for new agents not yet available. The briefing discusses the drugs currently in clinical trials, provides epidemiological information, and profiles the major competitors. The information presented in this report is the result of primary and secondary research. Secondary research included data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. Primary research consisted of interviews and correspondance with company executives, clinicians, researchers and public health officials. The market forecasts are based on epidemiology, historical growth rates, probable product introductions, analyst expectations, and expert consensus. Contents: CHAPTER ONE: EXECUTIVE SUMMARY Epidemiology Management of Schizophrenia Drugs in Development Market Summary World Market for Novel Antipsychotics Scope and Methodology CHAPTER TWO: INTRODUCTION Schizophrenia Symptoms Economic Burden Causes Complications Distorted Perceptions of Reality Hallucinations and Illusions Delusions Incidence Types CHAPTER THREE: TREATMENT OPTIONS Pharmacological Treatments Relapse Management Adherence Non-Pharmacological Treatments Psychosocial Treatments CHAPTER FOUR: DRUGS IN CLINICAL TRIALS Newer Treatment Approaches Preclinical Agents A320436 Dopamine D2 Partial Agonist Agent ORG 25543 MEM 3454 Clera 120 Phase I Clinical Agents LY 483518 SB 277011 MGS 0028 Muscarinic M1 Agonist Compound SGS 518 Neboglamine Phase II Clinical Agents DAR 0100 Palindore Reminertant Lurasidone Talnetant Phase III Clinical Agents Bifeprunox Lonasen Iloperidone CHAPTER FIVE: MARKET FORECASTS Opportunities and Drivers World Market Breakdown 5H2 and D2 Antagonist Antipsychotic Agents Atypical Antipsychotic Agents 5H1A and D2 Partial Agonist and D2 and D3 Antagonist Agents Novel Antipsychotic Agents Geographical Breakdown of Antipsychotic Agents CHAPTER SIX: KEY PLAYERS Astra Zeneca PLC Abbott Laboratories Johnson and Johnson Novartis AG Pfizer Inc. LIST OF EXHIBITS Exhibit 1: Schizophrenia Cases, Geographical Breakdown Exhibit 2: Status of Key Late-Stage Antipsychotic Agents Exhibit 3: World Market for Antipsychotics Summary 2004-2009 Exhibit 4: World Market for Antipsychotics by Geographic Segment Summary 2004-2009 Exhibit 5: World Market for Antipsychotics by Drug Type Summary 2004-2009 Exhibit 6: World Market for Novel Antipsychotics 2006-2009 Exhibit 7: Schizophrenia Cases, Geographical Breakdown Exhibit 8: World Market for Antipsychotic Agents 2004-2009 Exhibit 9: Expected Launch Dates of Late Stage Antipsychotic Agents Exhibit 10: World Market for Antipsychotics by Drug Type (5 H2 & D2 antagonists, atypical antipsychotics, 5 H1A & D2 partial agonist, D2 & D3 antagonists, and benzamides) 2004-2009 Exhibit 11: World Market for 5H2 and D2 Antagonist Segment Exhibit 12: World Market for Atypical Antipsychotic Segment Exhibit 13: World Market for 5H1A and D2 Partial Agonist Segment Exhibit 14: World Market for D2 and D3 Antagonist Segment Exhibit 15: World Market for Novel Antipsychotic Therapies 2006-2009 Exhibit 16: World Market for Antipsychotics by Geographic Segment (U.S., Europe, Japan, ROW) 2004-2009 Ordering: Order Online - http://www.researchandmarkets.com/reports/2860693/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Schizophrenia Therapeutics: A Market Briefing Web Address: http://www.researchandmarkets.com/reports/2860693/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Hard Copy: USD 995 + USD 58 Shipping/Handling Electronic (PDF) Single User: USD 995 Electronic (PDF) Enterprisewide: USD 1990 * Shipping/Handling is only charged once per order. Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World